Addithive Company Review · October 3, 2026
What changed
Henkel continues to support medical and industrial photopolymer applications through LOCTITE 3D materials, but no material 2026 AM-specific commercial catalyst is evident in current public disclosure.
Addithive read-through
The AM exposure is evaluated on whether it affects qualification, inspection, workflow integration, accepted-part economics or recurring production. A review with no new catalyst is deliberately labeled that way rather than being promoted as a false signal.
What to watch next
- Production-scale customer use and repeat orders.
- Workflow or material qualification milestones.
- Recurring software, consumables or service economics where relevant.
- Any disclosure that makes AM contribution financially material.
Primary sources
Research mapping only. This is not investment advice.